Liver Cirrhosis,Esophageal varices
Conditions
Interventions
Lusutrombopag 3mg/day, oral intake for 7 days
no medication
Sponsors
Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University,
National Hospital Organization Tokyo Medical Center SANOKOUSEI GENERAL HOSPITAL Kitasato Institute Hospital Tokyo Dental College Ichikawa General Hospital Tokyo Saiseikai Central Hospital Yokohama Municipal Citizen'
s Hospital Eiju Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: eligible patients had liver cirrhosis (Child-Pugh score A or B), and a platelet count of more than 40000 to less than 80000 per cubic millimeter.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had a history of hypersensitivity of lusutrombopag, or if they were pregnant, or they had a history of arterial or venous thrombosis with on-going risk factors for thrombosis, or had a severe liver damages (Child-Pugh score C), or had a severe renal dysfunction, or took anticoagulant or antiplatelet drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total procedure time of EIS | — |
Secondary
| Measure | Time frame |
|---|---|
| number of balloon compression times, bleeding time, delayed post EIS bleeding, adverse events | — |
Countries
Japan
Contacts
Public ContactKaoru Takabayashi
Keio University school of medicine Center for Diagnostic and Therapeutic Endoscopy
Outcome results
None listed